Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2025-12-29 @ 11:16 PM
Study NCT ID:
NCT01468350
Status:
COMPLETED
Last Update Posted:
2014-06-24
First Post:
2011-11-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy
Sponsor:
Acorda Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2013-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-07
First Submit QC Date:
None
Study First Post Date:
2011-11-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-03-24
Results First Submit QC Date:
None
Results First Post Date:
2014-06-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-22
Last Update Post Date:
2014-06-24
Last Update Post Date Type:
ESTIMATED